Prostate cancer screening at an equal access tertiary care center: its impact 10 years after the introduction of PSA

• Published in: Prostate cancer and prostatic diseases Vol. 5; no. 1; pp. 32 - 35
• Main Authors: Soderdahl, D W, Hernandez, J
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 01.03.2002
• Subjects: Adult; Aged; Aged, 80 and over; Antigens; Biopsy; Cancer screening; Health care facilities; Hospitals, Military; Humans; Male; Mass Screening; Medical Records; Medical screening; Middle Aged; Palpation; Patients; Population studies; Prostate - pathology; Prostate cancer; Prostate-Specific Antigen - blood; Prostatic Neoplasms - blood; Prostatic Neoplasms - diagnosis; Prostatic Neoplasms - diagnostic imaging; Rectum; Retrospective Studies; Sensitivity and Specificity; Time Factors; Ultrasonography
• ISSN: 1365-7852; 1476-5608
• DOI: 10.1038/sj.pcan.4500555

Dwight D. Eisenhower Army Medical Center has been involved in Prostate Cancer Awareness Week (PCAW) screening during the period 1995-2000. The purpose of this study is to review the results of screening in a self-selected population of military beneficiaries at our institution. Screening involving a brief urologic history, digital rectal examination (DRE) and serum prostatic specific antigen (PSA) measurement was offered to our screening population. Patients with an elevated PSA (>4.0 ng/ml) and/or a suspicious DRE were considered for transrectal ultrasonography with prostate needle biopsy (TRUS/PNB). Patient health records were reviewed retrospectively and analyzed to determine patient demographic characteristics, PSA distribution, DRE results and cancer detection rates. A total of 455 screening visits were performed from 1995 to 2000, of which 426 visits were included for analysis. Mean age of the study population was 57.4 y (40-83). Seventy-one percent of the patients reported prior PSA screening visits. Forty-four patients met indications for biopsy. A total of 30 TRUS/PNB were performed demonstrating presence of cancer in three patients for an overall cancer detection rate of 0.7%. Our study shows that the overall prostate cancer detection rate at our institution is lower than detection rates previously reported in the literature. Potential reasons for this finding may include that the subjects participating in PCAW screening tended to be younger than in other series and that a majority of them had already undergone prior screening. These findings suggest the need to modify prostate cancer screening recommendations and to improve prostate cancer screening efficacy.